Health Care/Hospital

Coc Coc Shares Its Contribution in Fighting Against COVID-19 Epidemic

HANOI, Vietnam, May 15, 2020 /PRNewswire/ -- Vietnam has made efforts to implement measures of the COVID-19 prevention and achieved positive results. To contribute to this success, businesses, especially technology companies, have taken numerous practical actions. As a leading Vietnamese technolo...

2020-05-15 12:43 3875

Hilton Team Members Save Life of Guest Suffering Heart Attack

SHANGHAI, May 15, 2020 /PRNewswire/ -- A moving story was recently told far and wide in Suzhou City,Anhui Province. Frank Huang, Deputy Manager of Safety and Security, DoubleTree by Hilton Hotel Anhui – Suzhou, and fellow Team Members used first aid skills, developed through regular training, and...

2020-05-15 12:15 2963

Syntekabio Presents Nonclinical Data of immuno-oncologic agent STB-C017 at the 2020 AACR meeting

* STB-C017 is an IDO/TDO dual inhibitor, derived from Syntekabio's proprietary drug discovery artificial intelligence solution, demonstrated powerful immuno-oncologic effect. * Triple combination therapy of STB-C017, PD-1, CTLA-4 immune checkpoint inhibitors (ICIs) presented complete remiss...

2020-05-15 12:01 3675

Syntekabio Presents Nonclinical Data of immuno-oncologic agent STB-C017 at the 2020 AACR meeting

DAEJEON, South Korea, May 15, 2020 /PRNewswire/ -- Syntekabio (KOSDAQ: 226330), an AI and NGS based drug development company, presented the result of STB-C017 animal experiments, a small molecule IDO/TDO dual inhibitor derived by Syntekabio's AI drug discovery solution, at the 2020 American Assoc...

2020-05-15 12:01 4259

Duke-NUS, GenScript and A*STAR launch first-in-the-world SARS-CoV-2 serology test to detect neutralising antibodies without need of containment facility or specimen

* As a first-in-the-world "rapid smart test kit", the cPass™ which can measure neutralising antibodies in an hour will be a huge boost to current COVID-19 investigations, from contact tracing, sero-prevalence survey, and assessment of herd immunity, longevity of protective immunity and efficac...

2020-05-15 11:52 7414

Innovent Announces Key Results from a Number of Clinical Studies to Be Presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting

SUZHOU, China, May 15, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic and other major diseas...

2020-05-15 07:30 7797

/C O R R E C T I O N -- CAS/

In the news release, CAS Releases Special Report Highlighting COVID-19 Diagnostic Test Research, issued04-May-2020 by CAS over PR Newswire, we are advised by the company that in the first paragraph of the release, the title in quotations "Assay Techniques and Test Development for COVID-19 Diagnos...

2020-05-15 03:27 2607

Limacorporate Announces Plans for Phase 2 During the Coronavirus Crisis: Salaries Integrated to 100% for All Employees

SAN DANIELE DEL FRIULI, Italy, May 15, 2020 /PRNewswire/ -- LimaCorporate announces the Phase 2 plan during the coronavirus worldwide emergency which includes salaries to be integrated to 100% for all employees on social shock absorbers as more employees return to the company. LimaCorporate has ...

2020-05-15 01:15 3098

AGC Biologics to Participate in First-Ever BIO Digital Conference

SEATTLE, May 14, 2020 /PRNewswire/ -- AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), will be participating in the first-ever BIO Digital event. BIO International Conference is holding its annual event virtually this year in order to safely co...

2020-05-14 20:30 3686

INOVIO's INO-5401 in Combination with PD-1 Inhibitor Libtayo(R) (cemiplimab) Demonstrates 85% of Newly Diagnosed Glioblastoma Patients Are Alive 12 Months Following Treatment

PLYMOUTH MEETING, Pennsylvania, May 14, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO) today announced that 85 percent (44 out of 52) of patients newly diagnosed with the deadly brain cancer glioblastoma multiforme (GBM) who received the company's DNA medicine INO-5401, in combination with INO-9012 an...

2020-05-14 19:00 4227

SANANBIO and Hode AgTech Announce Strategic Partnership for Indoor Farming Projects in Qatar

XIAMEN, China, May 14, 2020 /PRNewswire/ -- SANANBIO, an industry-leading indoor farming solution provider, and Hode AgTech, agri-technologies developer and promoter, announced their partnership on indoor farming projects on the 13th of May, 2020.Zhan Zhuo, General Manager of SANANBIO, and Zhang M...

2020-05-14 18:11 1968

SciMount announces FDA approval of SMP-100's IND application for the treatment of Irritable Bowel Syndrome

CHENGDU, China, May 13, 2020 /PRNewswire/ -- SciMount Pharmatech, Co. Ltd., a wholly-owned subsidiary ofXiling Lab, announces today that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for SMP-100 for the treatment of Irritable Bowel Synd...

2020-05-14 18:00 1214

Yayasan Hasanah: Strategic Partnerships with Civil Society Organisations Impacted the Lives of 113,431 in 2019

KUALA LUMPUR, Malaysia, May 14, 2020 /PRNewswire/ -- Yayasan Hasanah ("Hasanah"), the foundation of Khazanah Nasional Berhad, continues to catalyse, empower and enable civil society organisations to undertake community initiatives that improves the lives of vulnerable individuals and families ac...

2020-05-14 16:58 2869

TCEB Launches MICE Venue Hygiene Guidelines Readying MICE Entrepreneurs for New Normal after Ease of Lockdown

BANGKOK, May 14, 2020 /PRNewswire/ -- Thailand Convention and Exhibition Bureau (Public Organization) or TCEB in collaboration with MICE stakeholder associations launches MICE Venue Hygiene Guidelines targeting MICE entrepreneurs to make them well-prepared for the resumption of businesses und...

2020-05-14 16:16 4838

Novartis Singapore returns Job Support Scheme payout worth SGD3.7 Million; aids community efforts against COVID-19

* Novartis Singapore commits to no retrenchments due to the COVID-19 pandemic, returnsSGD 3.7 million worth of Job Support Scheme (JSS) in April 2020 and declines any future payouts related to the pandemic. * The company has donated SGD 200,000 from the Novartis Global COVID-19 Response Fun...

2020-05-14 15:18 3876

Experts Underscore Essential Role for Patient Blood Management in and beyond the COVID-19 Pandemic

* Blood services and health authorities warn that a decline in donations due to COVID-19 could result in blood shortages, forcing frontline health care providers to face further difficult clinical decisions;[1],[2] * An international group of 43 medical experts points at a win-win concept to ...

2020-05-14 14:00 2813

Virtual pitching competition with 20 Swiss startups puts innovation center stage

SHANGHAI, May 14, 2020 /PRNewswire/ -- Following Switzerland's record-performance at CESASIA 2019 winning 6 CES Innovation Awards, SwissTech will be taking the stage again inAsia this 10 June – virtually! SwissTech Pitchinar 2020 is to be joined by 20 leading Swiss startups in the fields of Heal...

2020-05-14 13:18 4600

Orbitkey is Here to Lend a Helping Hand

MELBOURNE, Australia, May 14, 2020 /PRNewswire/ -- As a response to the COVID-19 pandemic,Melbourne-based organisation brand Orbitkey has utilised their product design expertise to create a Sanitiser Holder. They are giving away 500 units to those on the front line, and donating 100% of profits t...

2020-05-14 12:32 3450

MetroResidences Unveils Safe Home Programme to Facilitate Alternative Accommodations for Frontline Workers

SINGAPORE, May 14, 2020 /PRNewswire/ -- MetroResidences, a leading Tech-driven hospitality company has announced the launch of Safe Home Programme in Singapore and Japan. The initiative aims to support not only healthcare workers but also other...

2020-05-14 12:27 6391

Halodine(R) Nasal and Oral Antiseptics Show Rapid Antiviral Activity Against SARS-CoV-2 (COVID-19)

FORT LAUDERDALE, Florida, May 14, 2020 /PRNewswire/ -- Veloce BioPharma LLC reports today that their Halodine® Antiseptics have demonstrated rapid viricidal efficacy against SARS-CoV-2, the virus that causes COVID-19. Halodine® is a proprietary povidone-iodine antiseptic developed in partnership ...

2020-05-14 09:26 3343
1 ... 776777778779780781782 ... 847

Week's Top Stories